Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls

Human Molecular Genetics

Volumn 22, Issue 20, 2013, Pages 4194-4205

  Nickles, Dorothee ^a   Chen, Hsuan P ^a   Li, Michael M ^a   Khankhanian, Pouya ^a   Madireddy, Lohith ^a   Caillier, Stacy J ^a   Santaniello, Adam ^a   Cree, Bruce A C ^a   Pelletier, Daniel ^b,c   Hauser, Stephen L ^a   Oksenberg, Jorge R ^a   Baranzini, Sergio E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Neurology ^*  (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PROTEASOME; RNA; TRANSCRIPTOME;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RNA ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; WNT SIGNALING PATHWAY;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERFERONS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROTEASOME ENDOPEPTIDASE COMPLEX; QUANTITATIVE TRAIT LOCI; RNA; TRANSCRIPTOME; WNT SIGNALING PATHWAY; YOUNG ADULT;

EID: 84884713934     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt267     Document Type: Article

References (74)

1. Rosati, G. (2001) The prevalence of multiple sclerosis in the world: an update. Neurol. Sci., 22, 117-139.
2. Sospedra,M.and Martin, R. (2005)Immunology of multiple sclerosis. Annu. Rev. Immunol., 23, 683-747.
3. Oksenberg, J.R. and Baranzini, S.E. (2010) Multiple sclerosis genetics-is the glass half full, or half empty? Nat. Rev. Neurol., 6, 429-437.
4. Haines, J.L., Ter-Minassian, M., Bazyk, A., Gusella, J.F., Kim, D.J., Terwedow, H., Pericak-Vance, M.A., Rimmler, J.B., Haynes, C.S., Roses, A.D. et al. (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat. Genet., 13, 469-471.
5. Nagasaka, Y., Dillner, K., Ebise, H., Teramoto, R., Nakagawa, H., Lilius, L., Axelman, K., Forsell, C., Ito, A., Winblad, B. et al. (2005) A unique gene expression signature discriminates familial Alzheimer's disease mutation carriers from their wild-type siblings. Proc. Natl Acad. Sci. USA, 102, 14854-14859.
6. Olsen, N.J., Moore, J.H. and Aune, T.M. (2004) Gene expression signatures for autoimmunedisease in peripheral bloodmononuclear cells. Arthritis Res. Ther., 6, 120-128.
7. Tang, Y., Gilbert, D.L., Glauser, T.A., Hershey, A.D. and Sharp, F.R. (2005) Blood gene expression profiling of neurologic diseases: a pilot microarray study. Arch. Neurol., 62, 210-215.
8. Tang, Y., Xu, H., Du, X., Lit, L., Walker, W., Lu, A., Ran, R., Gregg, J.P., Reilly, M., Pancioli, A. et al. (2006) Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J. Cereb. Blood Flow Metab., 26, 1089-1102.
9. Pereira, E., Tamia-Ferreira, M.C., Cardoso, R.S., Mello, S.S., Sakamoto-Hojo, E.T., Passos, G.A. and Donadi, E.A. (2004) Immunosuppressive therapy modulates T lymphocyte gene expression in patients with systemic lupus erythematosus. Immunology, 113, 99-105.
10. Rotger, M., Dang, K.K., Fellay, J., Heinzen, E.L., Feng, S., Descombes, P., Shianna, K.V., Ge, D., Gunthard, H.F., Goldstein, D.B. et al. (2010) Genome-widemRNAexpression correlates of viral control inCD4+T-cells from HIV-1-infected individuals. PLoS Pathog., 6, e1000781.
11. Schmidt, S., Rainer, J., Riml, S., Ploner, C., Jesacher, S., Achmuller, C., Presul, E., Skvortsov, S., Crazzolara, R., Fiegl,M. et al. (2006) Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia. Blood, 107, 2061-2069.
12. Achiron, A., Gurevich, M., Friedman, N., Kaminski, N. and Mandel, M. (2004) Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity. Ann. Neurol., 55, 410-417.
13. Achiron, A., Feldman, A., Mandel, M. and Gurevich, M. (2007) Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse. Ann. NY Acad. Sci., 1107, 155-167.
14. Arthur, A.T., Armati, P.J., Bye, C., Heard, R.N., Stewart, G.J., Pollard, J.D. and Booth, D.R. (2008) Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission. BMC Med. Genet., 9, 17.
15. Bomprezzi, R., Ringner, M., Kim, S., Bittner, M.L., Khan, J., Chen, Y., Elkahloun, A., Yu, A., Bielekova, B., Meltzer, P.S. et al. (2003) Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum. Mol. Genet., 12, 2191-2199.
16. Booth, D.R., Arthur, A.T., Teutsch, S.M., Bye, C., Rubio, J., Armati, P.J., Pollard, J.D., Heard, R.N. and Stewart, G.J. (2005) Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis. J. Mol. Med. (Berl.), 83, 822-830.
17. Brynedal, B., Khademi, M., Wallstrom, E., Hillert, J., Olsson, T. and Duvefelt, K. (2010) Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery? Neurobiol. Dis., 37, 613-621.
18. Gandhi, K.S., McKay, F.C., Cox, M., Riveros, C., Armstrong, N., Heard, R.N., Vucic, S., Williams, D.W., Stankovich, J., Brown, M. et al. (2010) The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Hum. Mol. Genet., 19, 2134-2143.
19. Iglesias, A.H., Camelo, S., Hwang, D., Villanueva, R., Stephanopoulos, G. and Dangond, F. (2004) Microarray detection of E2F pathway activation and other targets in multiple sclerosis peripheral blood mononuclear cells. J. Neuroimmunol., 150, 163-177.
20. Martinelli-Boneschi, F., Fenoglio, C., Brambilla, P., Sorosina, M., Giacalone, G., Esposito, F., Serpente, M., Cantoni, C., Ridolfi, E., Rodegher, M. et al. (2012) MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers. Neurosci. Lett., 508, 4-8.
21. Menon, R., Di Dario, M., Cordiglieri, C., Musio, S., La Mantia, L., Milanese, C., Di Stefano, A.L., Crabbio, M., Franciotta, D., Bergamaschi, R. et al. (2012) Gender-based blood transcriptomes and interactomes in multiple sclerosis: involvement of SP1 dependent gene transcription. J. Autoimmun., 38, J144-J155.
22. Ramanathan, M., Weinstock-Guttman, B., Nguyen, L.T., Badgett, D., Miller, C., Patrick, K., Brownscheidle, C. and Jacobs, L. (2001) In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects. J. Neuroimmunol., 116, 213-219.
23. Riveros, C., Mellor, D., Gandhi, K.S., McKay, F.C., Cox, M.B., Berretta, R., Vaezpour, S.Y., Inostroza-Ponta, M., Broadley, S.A., Heard, R.N. et al. (2010) A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis. PLoS One, 5, e14176.
24. Sarkijarvi, S., Kuusisto, H., Paalavuo, R., Levula, M., Airla, N., Lehtimaki, T., Kaprio, J., Koskenvuo, M. and Elovaara, I. (2006) Gene expression profiles in Finnish twins with multiple sclerosis. BMC Med. Genet., 7, 11.
25. Satoh, J., Nakanishi, M., Koike, F., Miyake, S., Yamamoto, T., Kawai, M., Kikuchi, S., Nomura, K., Yokoyama, K., Ota, K. et al. (2005) Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Neurobiol. Dis., 18, 537-550.
26. Tian, Y., Apperson, M.L., Ander, B.P., Liu, D., Stomova, B.S., Jickling, G.C., Enriquez, R., Agius, M.A. and Sharp, F.R. (2011) Differences in exon expression and alternatively spliced genes in blood of multiple sclerosis compared to healthy control subjects. J. Neuroimmunol., 230, 124-129.
27. van Baarsen, L.G., van der Pouw Kraan, T.C., Kragt, J.J., Baggen, J.M., Rustenburg, F., Hooper, T., Meilof, J.F., Fero, M.J., Dijkstra, C.D., Polman, C.H. et al. (2006) A subtype of multiple sclerosis defined by an activated immune defense program. Genes Immun., 7, 522-531.
28. Ottoboni, L., Keenan, B.T., Tamayo, P., Kuchroo, M., Mesirov, J.P., Buckle, G.J., Khoury, S.J., Hafler, D.A., Weiner, H.L. and De Jager, P.L. (2012) An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity. Sci. Transl. Med., 4, 153ra131.
29. Achiron, A., Feldman, A., Magalashvili, D., Dolev, M. and Gurevich, M. (2012) Suppressed RNA-polymerase 1 pathway is associated with benign multiple sclerosis. PLoS One, 7, e46871.
30. Gurevich,M. and Achiron, A. (2012) The switch between relapse and remission in multiple sclerosis: continuous inflammatory response balanced by Th1 suppression and neurotrophic factors. J. Neuroimmunol., 252, 83-88.
31. Cox, M.B., Bowden, N.A., Scott, R.J. and Lechner-Scott, J. (2013) Altered expression of the plasminogen activation pathway in peripheral blood mononuclear cells in multiple sclerosis: possible pathomechanism of matrix metalloproteinase activation. Mult. Scler. [Epub ahead of print].
32. Cheung, V.G. and Spielman, R.S. (2009) Genetics of human gene expression: mappingDNAvariants that influence gene expression. Nat. Rev. Genet., 10, 595-604.
33. Cookson, W., Liang, L., Abecasis, G., Moffatt, M. and Lathrop, M. (2009) Mapping complex disease traits with global gene expression. Nat. Rev. Genet., 10, 184-194.
34. Lev, N., Ickowicz, D., Barhum, Y., Blondheim, N., Melamed, E. and Offen, D. (2006) Experimental encephalomyelitis induces changes in DJ-1: implications for oxidative stress in multiple sclerosis. Antioxid. Redox Signal., 8, 1987-1995.
35. Hirotani, M., Maita, C., Niino, M., Iguchi-Ariga, S., Hamada, S., Ariga, H. and Sasaki, H. (2008) Correlation between DJ-1 levels in the cerebrospinal fluid and the progression of disabilities in multiple sclerosis patients. Mult. Scler., 14, 1056-1060.
36. vanHorssen, J., Drexhage, J.A., Flor,T.,Gerritsen,W., van derValk, P. and de Vries, H.E. (2010)Nrf2 andDJ1 are consistently upregulated in inflammatory multiple sclerosis lesions. Free Radic. Biol. Med., 49, 1283-1289.
37. Benita, Y., Cao, Z., Giallourakis, C., Li, C., Gardet, A. and Xavier, R.J. (2010) Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor. Blood, 115, 5376-5384.
38. Ideker, T., Ozier, O., Schwikowski, B. and Siegel, A.F. (2002) Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics, 18 (Suppl. 1), S233-S240.
39. Shannon, P., Markiel, A., Ozier, O., Baliga, N.S., Wang, J.T., Ramage, D., Amin, N., Schwikowski, B. and Ideker, T. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res., 13, 2498-2504.
40. Baranzini, S.E., Wang, J., Gibson, R.A., Galwey, N., Naegelin, Y., Barkhof, F., Radue, E.W., Lindberg, R.L., Uitdehaag, B.M., Johnson, M.R. et al. (2009) Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum. Mol. Genet., 18, 767-778.
41. Condamine, T., Le Texier, L., Howie, D., Lavault, A., Hill, M., Halary, F., Cobbold, S., Waldmann, H., Cuturi, M.C. and Chiffoleau, E. (2010) Tmem176B and Tmem176A are associated with the immature state of dendritic cells. J. Leukoc. Biol., 88, 507-515.
42. Fissolo, N., Kraus, M., Reich, M., Ayturan, M., Overkleeft, H., Driessen, C. and Weissert, R. (2008) Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation. Eur. J. Immunol., 38, 2401-2411.
43. Mayo, I., Arribas, J., Villoslada, P., Alvarez DoForno, R., Rodriguez-Vilarino, S., Montalban, X., De Sagarra, M.R. and Castano, J.G. (2002) The proteasome is a major autoantigen in multiple sclerosis. Brain, 125, 2658-2667.
44. Mishto, M., Bellavista, E., Ligorio, C., Textoris-Taube, K., Santoro, A., Giordano, M., D'Alfonso, S., Listi, F., Nacmias, B., Cellini, E. et al. (2010) ImmunoproteasomeLMP260HHvariant altersMBPepitope generation and reduces the risk to develop multiple sclerosis in Italian female population. PLoS One, 5, e9287.
45. Sharma, M., Burre, J. and Sudhof, T.C. (2012) Proteasome inhibition alleviates SNARE-dependent neurodegeneration. Sci. Transl. Med., 4, 147ra113.
46. Wexler, E.M., Rosen, E., Lu, D., Osborn, G.E., Martin, E., Raybould, H. and Geschwind, D.H. (2011) Genome-wide analysis of a Wnt1-regulated transcriptional network implicates neurodegenerative pathways. Sci. Signal, 4, ra65.
47. Galimberti, D., Macmurray, J., Scalabrini, D., Fenoglio, C., De Riz, M., Comi, C., Comings, D., Cortini, F., Villa, C., Serpente, M. et al. (2011) GSK3beta genetic variability in patients with multiple sclerosis. Neurosci. Lett., 497, 46-48.
48. Fancy, S.P., Harrington, E.P., Yuen, T.J., Silbereis, J.C., Zhao, C., Baranzini, S.E., Bruce, C.C., Otero, J.J., Huang, E.J., Nusse, R. et al. (2011) Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat. Neurosci., 14, 1009-1016.
49. Fancy, S.P., Baranzini, S.E., Zhao, C., Yuk, D.I., Irvine, K.A., Kaing, S., Sanai, N., Franklin, R.J. and Rowitch, D.H. (2009) Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev., 23, 1571-1585.
50. Goertsches, R.H., Zettl, U.K. and Hecker, M. (2011) Sieving treatment biomarkers from blood gene-expression profiles: a pharmacogenomic update on two types of multiple sclerosis therapy. Pharmacogenomics, 12, 423-432.
51. Durinck, S., Moreau, Y., Kasprzyk, A., Davis, S., De Moor, B., Brazma, A. and Huber, W. (2005) BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics, 21, 3439-3440.
52. Kauffmann, A., Gentleman, R. and Huber,W.(2009) arrayQualityMetrics- a bioconductor package for quality assessment of microarray data. Bioinformatics, 25, 415-416.
53. Duan, S., Zhang, W., Bleibel, W.K., Cox, N.J. and Dolan, M.E. (2008) SNPinProbe_1.0: a database for filtering out probes in the Affymetrix GeneChip human exon 1.0 ST array potentially affected by SNPs. Bioinformation, 2, 469-470.
54. Smyth, G.K. (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol., 3, Article 3.
55. Falcon, S. and Gentleman, R. (2007) Using GOstats to test gene lists for GO term association. Bioinformatics, 23, 257-258.
56. Davis, S. and Meltzer, P.S. (2007) GEOquery: a bridge between the Gene Expression Omnibus (GEO) and Bioconductor. Bioinformatics, 23, 1846-1847.
57. Mishra, G.R., Suresh, M., Kumaran, K., Kannabiran, N., Suresh, S., Bala, P., Shivakumar, K., Anuradha, N., Reddy, R., Raghavan, T.M. et al. (2006) Human protein reference database - 2006 update. Nucleic Acids Res., 34, D411-D414.
58. Peri, S., Navarro, J.D., Amanchy, R., Kristiansen, T.Z., Jonnalagadda, C.K., Surendranath, V., Niranjan, V., Muthusamy, B., Gandhi, T.K., Gronborg,M. et al. (2003) Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res., 13, 2363-2371.
59. Prasad, T.S., Kandasamy, K. and Pandey, A. (2009) Human Protein Reference Database and Human Proteinpedia as discovery tools for systems biology. Methods Mol. Biol., 577, 67-79.
60. Bindea,G., Mlecnik,B.,Hackl,H.,Charoentong, P.,Tosolini, M.,Kirilovsky, A., Fridman,W.H., Pages, F., Trajanoski, Z. and Galon, J. (2009) ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics, 25, 1091-1093.
61. Zhang, C., Hanspers, K., Kuchinsky, A., Salomonis, N., Xu, D. and Pico, A.R. (2012) Mosaic: making biological sense of complex networks. Bioinformatics, 28, 1943-1944.
62. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J. et al. (2007)PLINK:a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
63. Hindorff, L.A., Sethupathy, P., Junkins, H.A., Ramos, E.M., Mehta, J.P., Collins, F.S. and Manolio, T.A. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl Acad. Sci. USA, 106, 9362-9367.
64. Xia, K., Shabalin, A.A., Huang, S., Madar, V., Zhou, Y.H., Wang, W., Zou, F., Sun, W., Sullivan, P.F. and Wright, F.A. (2012) seeQTL: a searchable database for human eQTLs. Bioinformatics, 28, 451-452.
65. Saiki, S., Sato, S. and Hattori, N. (2012)Molecular pathogenesis of Parkinson's disease: update. J. Neurol. Neurosurg. Psychiatry, 83, 430-436.
66. Bonifati, V., Dekker, M.C., Vanacore, N., Fabbrini, G., Squitieri, F., Marconi, R., Antonini, A., Brustenghi, P., Dalla Libera, A.,DeMari,M.et al. (2002) Autosomal recessive early onset parkinsonismis linked to three loci: PARK2, PARK6, and PARK7. Neurol. Sci., 23 (Suppl. 2), S59-S60.
67. Sun, Z., Ren, H., Liu, Y., Teeling, J.L. and Gu, J. (2011) Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response. J. Virol., 85, 1036-1047.
68. Dominguez, I., Sonenshein, G.E. and Seldin, D.C. (2009) Protein kinase CK2 in health and disease: CK2 and its role in Wnt and NF-kappaB signaling: linking development and cancer. Cell. Mol. Life Sci., 66, 1850-1857.
69. Harney, S.M., Vilarino-Guell, C., Adamopoulos, I.E., Sims, A.M., Lawrence, R.W., Cardon, L.R., Newton, J.L., Meisel, C., Pointon, J.J., Darke, C. et al. (2008) Fine mapping of the MHC Class III region demonstrates association of AIF1 and rheumatoid arthritis. Rheumatology (Oxford), 47, 1761-1767.
70. Bin, L., Howell, M.D., Kim, B.E., Hall, C.F., Streib, J.E. and Leung, D.Y. (2009) Inhibition of S100A11 gene expression impairs keratinocyte response against vaccinia virus through downregulation of the IL-10 receptor 2 chain. J. Allergy Clin. Immunol., 124, 270-277, 277.e271.
71. Mulcahy, H., O'Rourke, K.P., Adams, C., Molloy, M.G. and O'Gara, F. (2006) LST1 and NCR3 expression in autoimmune inflammation and in response to IFN-gamma, LPS and microbial infection. Immunogenetics, 57, 893-903.
72. Suzuki, T., Ishii-Watabe, A., Tada, M., Kobayashi, T., Kanayasu-Toyoda, T., Kawanishi, T. and Yamaguchi, T. (2010) Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR. J. Immunol., 184, 1968-1976.
73. Shi, Y., Chen, L., Liotta, L.A., Wan, H.H. and Rodgers, G.P. (2006) Glia maturation factor gamma (GMFG): a cytokine-responsive protein during hematopoietic lineage development and its functional genomics analysis. Genomics Proteomics Bioinformatics, 4, 145-155.
74. Du, H., Huang, X., Wang, S., Wu, Y., Xu, W. and Li, M. (2009) PSMA7, a potential biomarker of diseases. Protein Pept. Lett., 16, 486-489.